Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0001209191-23-040333

Options or other derivatives

  • Director acquired 1,950,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Magovcevic-Liebisch Ivana · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-22 Grant or award : show line 1 in the form Stock Option (right to buy) +1,950,000 1,950,000 D
Loading xslF345X04/doc4.xml…